456
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia

, , , &
Pages 541-546 | Received 30 Jan 2012, Accepted 27 Jul 2012, Published online: 22 Aug 2012

References

  • Rai KR, Holland JF, Glidewell OJ, . Treatment of acute myelocytic leukemia: a study by Cancer and Leukemia Group B. Blood 1981;58:1203–1212.
  • Grimwade D, Hills RK. Independent prognostic factors for AML outcome. Hematology Am Soc Hematol Educ Program 2009:385–395.
  • Ogden CL, Carroll MD, Curtin LR, . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549–1555.
  • Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer 2008;122: 1418–1421.
  • Castillo JJ, Reagan JL, Ingham RR, . Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res 2012;36:868–875.
  • Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004;23: 6365–6378.
  • Lange BJ, Gerbing RB, Feusner J, . Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203–211.
  • Lange BJ, Smith FO, Feusner J, . Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group. Blood 2008;111:1044–1053.
  • Thomas X, Fiere D, Archimbaud E. Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. Leukemia 1998;33:1503–1506.
  • Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet 2000;39:215–231.
  • Hanley MJ, Abernathy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans. Clin Pharmacokinet 2010;49: 71–87.
  • Fernandez HF, Sun Z, Yao X, . Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 2009;361:1249–1259.
  • Löwenberg B, Ossenkoppele GJ, van Putten W, . High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009;361:1235–1248.
  • Calle EE, Rodriguez C, Walker-Thurmond K, . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–1638.
  • Thompson LA, Lawson AP, Sutphin SD, . Description of current practices of empiric chemotherapy dose adjustment in obese adult patients. J Oncol Pract 2010;6:141–145.
  • Grimwade D, Walker H, Oliver F, . The importance of diagnostic cytogenetics on outcome in AML:analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322–2333.
  • Gallagher D, Visser M, Sepulveda D, . How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?Am J Epidemiol 1996;143:228–239.
  • Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLoS One 2012;7:e33308.
  • Di Monaco M, Vallero F, Di Monaco R, . Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr 2011;52:71–74.
  • Berrington de Gonzalez A, Hartge P, Cerhan JR, . Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211–2219.
  • Medeiros BC, Othus M, Fang M, . Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia. Haematologica 2012 Feb 7. [Epub ahead of print]
  • Ogden CL, Kuczmarksi RJ, Flegal KM, . Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45–80.
  • Berg SL, Bomgaars L, Twist C, . Impact of body composition on pharmacokinetics of doxorubicin in pediatric patients: a Glaser Pediatric Research Network study. J Clin Oncol 2005;23(16 Suppl.): Abstract8519.
  • Thompson PA, Rosner GL, Matthay KK, . Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemother Pharmacol 2009;64:243–251.
  • Kendrick JG, Carr RR, Ensom MH. Pharmacokinetics and drug dosing in obese children. J Pediatr Pharmacol Ther 2010;15: 94–109.
  • Calle EE, Rodriguez KC, Walker-Thurmond K, . Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–1638.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.